Pfizer Inc's experimental antiviral pill to treat Covid-19 cut by 89 per cent the chance of hospitalisation or death for adults at risk of severe disease, the company said, as its CEO vowed to make this promising new weapon in the fight against the pandemic available globally as quickly as possible.
